Literature DB >> 33570487

A cross-sectional study of pain status and psychological distress among individuals living with chronic pain: the Chronic Pain & COVID-19 Pan-Canadian Study.

M Gabrielle Pagé1,2, Anaïs Lacasse3, Lise Dassieu1, Maria Hudspith4, Gregg Moor4, Kathryn Sutton4, James M Thompson5,6, Marc Dorais7, Audrée Janelle Montcalm1, Nadia Sourial1,8, Manon Choinière1,2.   

Abstract

BACKGROUND: The COVID-19 pandemic has had a disproportionate impact on vulnerable populations, including individuals with chronic pain. We examined associations between geographical variations in COVID-19 infection rates, stress and pain severity, and investigated factors associated with changes in pain status and psychological distress among individuals living with chronic pain during the pandemic.
METHODS: This investigation is part of a larger initiative, the Chronic Pain & COVID-19 Pan-Canadian Study, which adopted a cross-sectional observational design. A total of 3159 individuals living with chronic pain completed a quantitative survey between 16 April and 31 May 2020.
RESULTS: Two-thirds (68.1%) of participants were between 40 and 69 years old, and 83.5% were women. Two-thirds (68.9%) of individuals reported worsened pain since pandemic onset. Higher levels of perceived pandemic-related risks (adjusted odds ratio: 1.27; 95% confidence interval: 1.03-1.56) and stress (1.21; 1.05-1.41), changes in pharmacological (3.17; 2.49-4.05) and physical/psychological (2.04; 1.62-2.58) pain treatments and being employed at the beginning of the pandemic (1.42; 1.09-1.86) were associated with increased likelihood of reporting worsened pain. Job loss (34.9% of individuals were employed pre-pandemic) was associated with lower likelihood (0.67; 0.48-0.94) of reporting worsened pain. Almost half (43.2%) of individuals reported moderate/severe levels of psychological distress. Negative emotions toward the pandemic (2.14; 1.78-2.57) and overall stress (1.43; 1.36-1.50) were associated with moderate/severe psychological distress.
CONCLUSIONS: Study results identified psychosocial factors to consider in addition to biomedical factors in monitoring patients' status and facilitating treatment access for chronic pain patients during a pandemic.

Entities:  

Keywords:  COVID-19; pain; pandemic; psychological distress

Mesh:

Year:  2021        PMID: 33570487     DOI: 10.24095/hpcdp.41.5.01

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   3.240


  12 in total

1.  Characteristics of Patients with Non-Cancer Pain and Perceived Severity of COVID-19 Related Stress.

Authors:  Jeffrey F Scherrer; Lisa R Miller-Matero; Joanne Salas; Mark D Sullivan; Scott Secrest; Kirsti Autio; Lauren Wilson; Matthew Amick; Lynn DeBar; Patrick J Lustman; Sarah Gebauer; Brian Ahmedani
Journal:  Mo Med       Date:  2022 May-Jun

2.  The impact of the COVID-19 pandemic on pain and psychological functioning in young adults with chronic pain.

Authors:  See Wan Tham; Caitlin B Murray; Emily F Law; Katherine E Slack; Tonya M Palermo
Journal:  Pain       Date:  2022-03-14       Impact factor: 7.926

3.  The Impact of the COVID-19 Pandemic on Youth with Chronic Pain and Their Parents: A Longitudinal Examination of Who Are Most at Risk.

Authors:  Kathryn A Birnie; Daniel C Kopala-Sibley; Maria Pavlova; Cara G Nania; Emily Bernier; Jennifer N Stinson; Melanie Noel
Journal:  Children (Basel)       Date:  2022-05-19

4.  The impact of COVID-19 on patients with chronic pain seeking care at a tertiary pain clinic.

Authors:  Maisa S Ziadni; Dokyoung S You; Eric M Cramer; Steven R Anderson; Gabrielle Hettie; Beth D Darnall; Sean C Mackey
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

5.  Pain experiences among women in midlife with existing health conditions: changes across pre-COVID-19, stay-at-home orders, and initial reopening.

Authors:  Danielle Arigo; Laura Travers; Laura M König
Journal:  Psychol Health       Date:  2022-01-21

6.  Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study.

Authors:  Anaïs Lacasse; M Gabrielle Pagé; Lise Dassieu; Nadia Sourial; Audrée Janelle-Montcalm; Marc Dorais; Hermine Lore Nguena Nguefack; Marimée Godbout-Parent; Maria Hudspith; Gregg Moor; Kathryn Sutton; James M Thompson; Manon Choinière
Journal:  Pain Rep       Date:  2021-02-08

7.  Pain catastrophizing mediates rapid benefits of accessing in-person chiropractic care during the COVID-19 lockdown.

Authors:  Carlos Gevers-Montoro; Zoha Deldar; Francisco Miguel Conesa-Buendía; Eric Arthur Lazar; Ignacio Mahillo-Fernandez; Ali Khatibi; Arantxa Ortega de Mues
Journal:  Eur J Pain       Date:  2021-10-15       Impact factor: 3.651

8.  Experiences of Pediatric Pain Professionals Providing Care during the COVID-19 Pandemic: A Qualitative Study.

Authors:  Tieghan Killackey; Krista Baerg; Bruce Dick; Christine Lamontagne; Raju Poolacherla; G Allen Finley; Melanie Noel; Kathryn A Birnie; Manon Choinière; M Gabrielle Pagé; Lise Dassieu; Anaïs Lacasse; Chitra Lalloo; Patricia Poulin; Samina Ali; Marco Battaglia; Fiona Campbell; Lauren Harris; Vina Mohabir; Fareha Nishat; Myles Benayon; Isabel Jordan; Jennifer Stinson
Journal:  Children (Basel)       Date:  2022-02-09

9.  Stress and Pain Before, During and After the First Wave of the COVID-19 Pandemic: An Exploratory Longitudinal Mixed Methods Study.

Authors:  M Gabrielle Pagé; Lise Dassieu; Élise Develay; Mathieu Roy; Étienne Vachon-Presseau; Sonia Lupien; Pierre Rainville
Journal:  Front Pain Res (Lausanne)       Date:  2021-11-24

Review 10.  Effectiveness of Telematic Behavioral Techniques to Manage Anxiety, Stress and Depressive Symptoms in Patients with Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis.

Authors:  Ferran Cuenca-Martínez; Luis Suso-Martí; Aida Herranz-Gómez; Clovis Varangot-Reille; Joaquín Calatayud; Mario Romero-Palau; María Blanco-Díaz; Cristina Salar-Andreu; Jose Casaña
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.